SCHEMBL8043656

SCHEMBL8043656

C=C(O)c1ccc(Oc2ccc(C)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP13 P45452 3/20 0.53
▸ TEAD4 Q15561 1/20 0.50
▸ ALDH1A1 P00352 4/20 0.48
▸ MAPT P10636 2/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ POLB P06746 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ MAPK14 Q16539 2/20 0.45
▸ HPGD P15428 3/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ SMN1; SMN2 Q16637 5/20 0.44
▸ HTT P42858 3/20 0.44
▸ GFER P55789 1/20 0.44
▸ HSD17B1 P14061 1/20 0.41
▸ HSD17B2 P37059 1/20 0.41
▸ ACHE P22303 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ MMP2 P08253 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10282614 0.86 ALDH1A1 (0.55) ALDH1A1MAPTKMT2ATDP1MEN1
SCHEMBL22917100 0.82 LTA4H (0.57) SMN1; SMN2TSHRPARP10
SCHEMBL12643206 0.79 MMP13 (0.50) MMP13TEAD4ALDH1A1MAPTKMT2A
SCHEMBL17679407 0.79 MMP13 (0.50) MMP13TEAD4ALDH1A1MAPTKMT2A
SCHEMBL19412563 0.79 MMP13 (0.50) MMP13TEAD4ALDH1A1MAPTKMT2A
SCHEMBL6034956 0.78 ALDH1A1 (0.74) MMP13ALDH1A1MAPTKMT2AMAPK14
SCHEMBL95343 0.78 TEAD4 (0.74) MMP13TEAD4ALDH1A1MAPTKMT2A
SCHEMBL83814 0.78 TEAD4 (0.74) MMP13TEAD4ALDH1A1MAPTKMT2A
SCHEMBL83863 0.78 TEAD4 (0.74) MMP13TEAD4ALDH1A1MAPTKMT2A
SCHEMBL16442727 0.78 MMP13 (0.49) MMP13TEAD4ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009062676-A2 IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC. (US) 2009-05-22 — — WO disclosed
Send feedback